Autologous tolerogenic dendritic cells (ATDC) for highly sensitized kidney transplant recipients
ATDC-PICI
Phase 1 other active
Quick answer
Autologous tolerogenic dendritic cells (ATDC) for highly sensitized kidney transplant recipients for Kidney trasplants is a Phase 1 program (other) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Kidney trasplants
- Phase
- Phase 1
- Modality
- other
- Status
- active